Silke Wolterink

Title: Silke Wolterink: Innovator in Tumor Treatment

Introduction

Silke Wolterink is a prominent inventor based in Weinheim, Germany. She has made significant contributions to the field of cancer research, particularly in the treatment of tumors. Her innovative work has led to the development of a specific anti-L1 antibody that holds promise for therapeutic applications.

Latest Patents

Silke Wolterink holds 1 patent related to her groundbreaking work. The patent, titled "Treatment of tumors using specific anti-L1 antibody," focuses on the anti-L1 monoclonal antibody 9.3 and its related antibodies or binding molecules. This invention is particularly relevant for tumor treatment, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Silke has worked with esteemed organizations such as the Deutsches Krebsforschungszentrum Stiftung Des Öffentlichen Rechts and Medigene AG. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to significant advancements in cancer treatment.

Collaborations

Silke has collaborated with notable professionals, including Daniela Kelm and Peter Altevogt. These partnerships have enriched her research and expanded the impact of her innovations in the medical community.

Conclusion

Silke Wolterink's contributions to tumor treatment through her innovative patent demonstrate her dedication to improving healthcare outcomes. Her work continues to inspire advancements in cancer research and treatment methodologies.